Home
Structure Therapeutics

Structure Therapeutics Market Share Analysis for June 2026

Medicine is our platform. Accessibility is our cure.

Health > Biotechnology and Pharmaceuticals

Domainstructuretx.com

Year Founded2017

Employees51 - 200

Annual Revenue--

Structure Therapeutics

Structure Therapeutics (including company regionals)

structuretx.com

See more website traffic and engagement information

Total visits to Structure Therapeutics's top domains

Understand Structure Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

structuretx.com13.2K

See more with Sales Intelligence

Avg. visit duration in Structure Therapeutics's top domains

Analyze Structure Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

structuretx.com00:00:45

See more with Sales Intelligence

Avg. pageviews on Structure Therapeutics's top domains

See how Structure Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

structuretx.com2.03

See more with Sales Intelligence

Structure Therapeutics top competitors by domain

Top similar sites in June 2026, ranked by their affinity

schrodinger.comCompany NameSchrodinger, Inc.Employees501 - 1000HQUnited States, New York, New YorkAnnual revenue$100M - $200MTotal visits158.9KScience and Education > Chemistry

Top technologies used by Structure Therapeutics

These are the website technologies, by industry, used by Structure Therapeutics top domains

Conversion & Analytics (2)

Google Analytics

Mobile (2)

Meta Viewport

Widget (2)

Twemoji

Audio Video Media (1)

Vimeo

More Technologies

6

See all

News & Signals from Structure Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsStructure Therapeutics, Inc. hired Matthew Lang as Chief Operating Officer and General Counsel on Jul 1st '25.Structure Therapeutics appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel.

NewsStructure Therapeutics, Inc. identified as competitor of Novo Nordisk A/S on Mar 16th '26.Structure Therapeutics Inc.'s shares rose after more data on the company's experimental weight-loss pill showed it's shaping up to rival new oral treatments from Novo Nordisk A/S and Eli Lilly & Co. Patients on Structure's once-daily pill, called aleniglipron, lost about 15% of their body weight after 44 weeks, while those given a placebo added a few pounds, the company said on Monday.

NewsStructure Therapeutics, Inc. launches aleniglipron.Structure Therapeutics just dropped some thrilling news about its new daily weight-loss pill, aleniglipron.